A breakdown of whether biotech startups really need VC—or if bootstrapping, grants, and partnerships can work.

Biotech down rounds are tough—see how to protect equity, restructure smartly, and position your startup for a stronger next raise.

From patents to trade secrets, learn how life sciences investors evaluate IP to gauge risk, market fit, and funding readiness.

Just raised a seed round? Discover the strategic steps founders should take to manage capital, hire smart, and scale effectively.

Strong IP is key to biotech funding—see why VCs scrutinize patents, trade secrets, and defensibility before investing.

Biotech startups face VC hurdles, long timelines, and high costs—learn why scaling remains a major challenge in today’s market.